We are very proud to announce that LUPUS EUROPE has been recognized by the EMA (European Medicine Agency) as “eligible entity”, the select network of patient organizations that work with the EMA to ensure that the needs and concerns of a wide range of patients are represented via direct contact with the Agency. This status is granted after an extensive evaluation and confirmation that we fulfill all eligibility criterions for working with EMA.

As an eligible organization, we will now receive targeted EMA communications and consultations and assist in the identification of experts for product-specific matters. Today already, 3 members of our Patient Advisory Network are assisting the EMA on specific requests raised to us.

This is a great development in our continued progress towards our Strategic Objective #1 : “that people with lupus in Europe participate in, and benefit from, lupus research”. Thanks to this new step, we will be in an even better position to bring the voice of people with lupus in clinical trials design, patient relevant outcome measurements, pharmaco-vigilance, drug authorization or other topics relevant to EMA.

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons
5 days ago

As much as we love hearing from you all and appreciate the time you take to share how you #kicklupus and inspire others, we cannot allow any content specifically about healing products for lupus.

We would greatly appreciate if you followed this rule when posting on the page.
Thank you
... See MoreSee Less

1 week ago

#WorldLupusDay finishes today, but #lupusawareness does not. There is so much more we can do to make life with #lupus better. Watch our vice chair, Anne Charlet, talk about her journey of becoming a Board Member.
You can also join us and become a volunteer
... See MoreSee Less

Comment on Facebook

Wauvvvv SO good looking :-)

LUPUS EUROPE Uniting people with Lupus throughout Europe